NDC 72934-5139

LIDOCAINE 2% / MUPIROCIN 2%

Lidocaine 2% / Mupirocin 2%

LIDOCAINE 2% / MUPIROCIN 2% is a Topical Ointment in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Mupirocin; Lidocaine.

• Product ID: 72934-5139_88de6337-6871-7248-e053-2a95a90ae412
• NDC: 72934-5139
• Product Type: Human Prescription Drug
• Proprietary Name: LIDOCAINE 2% / MUPIROCIN 2%
• Generic Name: Lidocaine 2% / Mupirocin 2%
• Dosage Form: Ointment
• Route of Administration: TOPICAL
• Marketing Start Date: 2019-05-15
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: Sincerus Florida, LLC
• Substance Name: MUPIROCIN; LIDOCAINE
• Active Ingredient Strength: 2 g/100g; g/100g
• Pharm Classes: RNA Synthetase Inhibitor Antibacterial [EPC],RNA Synthetase Inhibitors [MoA],Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 72934-5139-2

30 g in 1 BOTTLE, PUMP (72934-5139-2)

• Marketing Start Date: 2019-05-15
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 72934-5139-2 [72934513902]

LIDOCAINE 2% / MUPIROCIN 2% OINTMENT

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2019-05-15

Drug Details

Active Ingredients

Ingredient	Strength
MUPIROCIN	2 g/100g

OpenFDA Data

• SPL SET ID: 88de6337-6870-7248-e053-2a95a90ae412
• Manufacturer:
  • Sincerus Florida, LLC
• UNII:
  • 98PI200987
  • D0GX863OA5

Pharmacological Class

• RNA Synthetase Inhibitor Antibacterial [EPC]
• RNA Synthetase Inhibitors [MoA]
• Amide Local Anesthetic [EPC]
• Amides [CS]
• Antiarrhythmic [EPC]
• Local Anesthesia [PE]
• RNA Synthetase Inhibitor Antibacterial [EPC]
• RNA Synthetase Inhibitors [MoA]
• Amide Local Anesthetic [EPC]
• Amides [CS]
• Antiarrhythmic [EPC]
• Local Anesthesia [PE]